APA aipamena

Toosi, B. M., El Zawily, A., Truitt, L., Shannon, M., Allonby, O., Babu, M., . . . Freywald, A. (2018). EPHB6 augments both development and drug sensitivity of triple-negative breast cancer tumours. Oncogene.

Chicago Style aipamena

Toosi, Behzad M., et al. "EPHB6 Augments Both Development and Drug Sensitivity of Triple-negative Breast Cancer Tumours." Oncogene 2018.

MLA aipamena

Toosi, Behzad M., et al. "EPHB6 Augments Both Development and Drug Sensitivity of Triple-negative Breast Cancer Tumours." Oncogene 2018.